Table 1.
Higher abundance in | ||||||
---|---|---|---|---|---|---|
EVs | EAgo-1 | Intra | ||||
bantam-3p | ns | ns | S2 | (*) | ||
miR-2-3p | ns | ns | Cl.8 | (**) | ||
miR-14-3p | ns | ns | Cl.8 | (**) | ||
miR-34-5p | ns | ns | Cl.8 | (****) | ||
miR-276a-3p | S2 | (*) | ns | ns | ||
miR-252-5p | S2 | (****) | S2 | (*) | S2 | (****) |
miR-1-3p | Cl.8 | (**) | Cl.8 | (**) | Cl.8 | (****) |
miR-125-5p | S2 | (*) | Cl.8 | (**) | Cl.8 | (****) |
miR-210-3p | S2 | (****) | Cl.8 | (*) | Cl.8 | (***) |
let-7-5p | S2 | (****) | Cl.8 | (**) | Cl.8 | (****) |
miR-100-5p | S2 | (***) | Cl.8 | (*) | Cl.8 | (****) |
Significant differences (p) (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). Abbreviations: EVs: extracellular vesicles; EAgo-1: extracellular Argonaute-1 containing immunoprecipitates; Intra: intracellular; ns: not significant.